Somatic copy-number alteration analyses from more than 3000 specimens have revealed that Ccnd1, Cdk4, Cdk6, and Ccne1 genes were listed in 30 of the most amplified genes associated with cancer, which highlight their potential as anti-cancer therapeutic targets 25, 26. This evidence concerns the gene CDK6 and cancer.